OKYO Pharma (LON:OKYO) Trading Down 24.3%

OKYO Pharma Limited (LON:OKYOGet Free Report)’s stock price dropped 24.3% during mid-day trading on Thursday . The stock traded as low as GBX 1.40 ($0.02) and last traded at GBX 1.40 ($0.02). Approximately 364,142 shares traded hands during mid-day trading, a decline of 16% from the average daily volume of 431,999 shares. The stock had previously closed at GBX 1.85 ($0.02).

OKYO Pharma Price Performance

The company has a debt-to-equity ratio of 1.65, a quick ratio of 2.65 and a current ratio of 0.83. The firm has a fifty day simple moving average of GBX 1.40 and a 200 day simple moving average of GBX 1.40. The company has a market capitalization of £23.24 million, a PE ratio of -140.00 and a beta of -0.06.

OKYO Pharma Company Profile

(Get Free Report)

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain.

Read More

Receive News & Ratings for OKYO Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OKYO Pharma and related companies with MarketBeat.com's FREE daily email newsletter.